No abstract available
MeSH terms
-
Benzoates / adverse effects
-
Benzoates / therapeutic use
-
CCR5 Receptor Antagonists*
-
Clinical Trials as Topic
-
Clinical Trials, Phase II as Topic
-
Cyclohexanes / adverse effects
-
Cyclohexanes / therapeutic use
-
Diketopiperazines
-
HIV Fusion Inhibitors / adverse effects*
-
HIV Fusion Inhibitors / therapeutic use*
-
HIV Infections / drug therapy*
-
HIV-1 / drug effects
-
Humans
-
Maraviroc
-
Piperazines / adverse effects
-
Piperazines / therapeutic use
-
Pyrimidines / adverse effects
-
Pyrimidines / therapeutic use
-
Spiro Compounds / adverse effects
-
Spiro Compounds / therapeutic use
-
Treatment Outcome
-
Triazoles / adverse effects
-
Triazoles / therapeutic use
Substances
-
Benzoates
-
CCR5 Receptor Antagonists
-
Cyclohexanes
-
Diketopiperazines
-
HIV Fusion Inhibitors
-
Piperazines
-
Pyrimidines
-
Spiro Compounds
-
Triazoles
-
aplaviroc
-
Maraviroc
-
vicriviroc